Deep vein thrombosis assessment of probability of subsequent VTE and risk scores: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 2: | Line 2: | ||
{| class="infobox" style="float:right;" | {| class="infobox" style="float:right;" | ||
|- | |- | ||
| [[File:Siren.gif | | [[File:Siren.gif|link=Venous thromboembolism prevention resident survival guide|41x41px]]|| <br> || <br> | ||
| [[Venous thromboembolism prevention resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | | [[Venous thromboembolism prevention resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | ||
|} | |} | ||
Line 20: | Line 20: | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Variable'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score''' | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Variable'''|| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Score''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | Active [[cancer]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 3 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" | Active [[cancer]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" | 3 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Previous [[VTE]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Previous [[VTE]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |3 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Decreased mobility||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Decreased mobility|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |3 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Thrombophilia]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Thrombophilia]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |3 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Previous trauma or surgery within that last month||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Previous trauma or surgery within that last month|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Age≥ 70||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Age≥ 70|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Heart failure|Heart]] and/or [[respiratory failure]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Heart failure|Heart]] and/or [[respiratory failure]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Ischemic stroke]] or [[acute myocardial infarction]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Ischemic stroke]] or [[acute myocardial infarction]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Acute rheumatologic disorder and/or acute infection||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Acute rheumatologic disorder and/or acute infection|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Obesity]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Obesity]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Hormonal therapy]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Hormonal therapy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|} | |} | ||
Line 51: | Line 51: | ||
===IMPROVE Predictive Score for VTE=== | ===IMPROVE Predictive Score for VTE=== | ||
[[IMPROVE Score Calculator|'''IMPROVE Score Calculator''']] | |||
====Calculation of the IMPROVE Predictive Score==== | ====Calculation of the IMPROVE Predictive Score==== | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Variable'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Variable'''|| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Score'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | Prior episode of [[VTE]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 3 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" | Prior episode of [[VTE]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" | 3 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Thrombophilia]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Thrombophilia]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |3 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Malignancy]]||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Malignancy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Age more than 60 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Age more than 60 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|} | |} | ||
Line 68: | Line 70: | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Predicted VTE risk through 3 months'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Score'''|| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Predicted VTE risk through 3 months'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 0|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |0.5% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" | 0|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |0.5% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.0% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1.0% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.7% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1.7% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3.1% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |3|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |3.1% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |4|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |5.4% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |4|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |5.4% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |5-8|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |11% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |5-8|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |11% | ||
|} | |} | ||
Line 89: | Line 91: | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Variable'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Variable'''|| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Score'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | Prior episode of [[VTE]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 3 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" | Prior episode of [[VTE]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" | 3 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[Thrombophilia]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[Thrombophilia]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Paralysis of the lower extremity during the hospitalization||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Paralysis of the lower extremity during the hospitalization|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Current [[malignancy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Current [[malignancy]]|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Immobilization for at least 7 days|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Immobilization for at least 7 days|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |[[ICU]] or [[CCU]] admission|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |[[ICU]] or [[CCU]] admission|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |Age more than 60 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1 | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |Age more than 60 years|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1 | ||
|} | |} | ||
Line 109: | Line 111: | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Score'''||style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align=center | '''Predicted VTE risk through 3 months'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> | | style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Score'''|| style="padding: 0 5px; font-size: 100%; background: #F5F5F5;" align="center" | '''Predicted VTE risk through 3 months'''<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | 0|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |0.4% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" | 0|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |0.4% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |0.6% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |0.6% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2||style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.0% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1.0% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |3|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |1.7% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |3|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |1.7% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |4|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |2.9% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |4|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |2.9% | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |5-10|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |7.2% | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |5-10|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align="left" |7.2% | ||
|} | |} | ||
Line 130: | Line 132: | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align=center |'''Variable'''|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align=center |'''Score'''<ref name="pmid17544079">{{cite journal| author=Rogers SO, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF| title=Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. | journal=J Am Coll Surg | year= 2007 | volume= 204 | issue= 6 | pages= 1211-21 | pmid=17544079 | doi=10.1016/j.jamcollsurg.2007.02.072 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17544079 }} </ref> | | style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align="center" |'''Variable'''|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align="center" |'''Score'''<ref name="pmid17544079">{{cite journal| author=Rogers SO, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF| title=Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. | journal=J Am Coll Surg | year= 2007 | volume= 204 | issue= 6 | pages= 1211-21 | pmid=17544079 | doi=10.1016/j.jamcollsurg.2007.02.072 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17544079 }} </ref> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Pulmonary and hemic surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 9 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Pulmonary and hemic surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 9 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Thoracoabdominal [[aneurysm]], [[Pulmonary embolectomy|embolectomy]]/[[thrombectomy]], venous reconstruction, and endovascular repair surgery ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 7 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Thoracoabdominal [[aneurysm]], [[Pulmonary embolectomy|embolectomy]]/[[thrombectomy]], venous reconstruction, and endovascular repair surgery || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 7 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Aneurysm]] surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 4 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[Aneurysm]] surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 4 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Mouth or palate surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 4 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Mouth or palate surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 4 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Stomach or intestines surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 4 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Stomach or intestines surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 4 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Integument surgery||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 3 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Integument surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 3 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Hernia]] surgery||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 2 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[Hernia]] surgery|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 2 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[American Society of Anesthesiologists physical status classifications|American Society of Anesthesiologists (ASA) physical status classification]] 3, 4, or 5|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 2 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[American Society of Anesthesiologists physical status classifications|American Society of Anesthesiologists (ASA) physical status classification]] 3, 4, or 5|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 2 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[ASA physical status classification]] 2|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 1 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[ASA physical status classification]] 2|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 1 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Female || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 1 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Female || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 1 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Work relative value unit > 17 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 3 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Work relative value unit > 17 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 3 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Work relative value unit 10−17 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 2 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Work relative value unit 10−17 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 2 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Disseminated [[malignancy]]||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 2 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Disseminated [[malignancy]]|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 2 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Chemotherapy]] for [[cancer]] in the last 30 days||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 2 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[Chemotherapy]] for [[cancer]] in the last 30 days|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 2 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Hypernatremia|Serum sodium > 145 mmol/L]] pre-op||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 2 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[Hypernatremia|Serum sodium > 145 mmol/L]] pre-op|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 2 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Transfusion]] > 4 U packed [[red blood cells]] within 72 h pre-op||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 2 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[Transfusion]] > 4 U packed [[red blood cells]] within 72 h pre-op|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 2 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Dependency on ventilator||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 2 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Dependency on ventilator|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 2 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Wound class (clean/contaminated)||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 1 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Wound class (clean/contaminated)|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 1 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Hematocrit]] ≤ 38% pre-op||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 1 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[Hematocrit]] ≤ 38% pre-op|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 1 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Bilirubin]] > 1.0 mg/dL pre-op||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 1 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[Bilirubin]] > 1.0 mg/dL pre-op|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 1 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Dyspnea]]||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 1 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[Dyspnea]]|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 1 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[Albumin]] ≤ 3.5 mg/dL||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 1 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[Albumin]] ≤ 3.5 mg/dL|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 1 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Emergency operation||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 1 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Emergency operation|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 1 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | [[ASA physical status classification]] 1||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 0 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | [[ASA physical status classification]] 1|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 0 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Work relative value unit < 10||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 0 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Work relative value unit < 10|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 0 | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | Male||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | 0 | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | Male|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 0 | ||
|} | |} | ||
Line 193: | Line 195: | ||
===Caprini Risk Assessment Model=== | ===Caprini Risk Assessment Model=== | ||
====Calculation of the Caprini Risk Score==== | ====Calculation of the Caprini Risk Score==== | ||
'''[[Caprini score calculator]]''' | |||
Shown below is a table depicting the different scores for the factors included in the Caprini score.<ref name="pmid1754886">{{cite journal| author=Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F| title=Clinical assessment of venous thromboembolic risk in surgical patients. | journal=Semin Thromb Hemost | year= 1991 | volume= 17 Suppl 3 | issue= | pages= 304-12 | pmid=1754886 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1754886 }} </ref> | Shown below is a table depicting the different scores for the factors included in the Caprini score.<ref name="pmid1754886">{{cite journal| author=Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F| title=Clinical assessment of venous thromboembolic risk in surgical patients. | journal=Semin Thromb Hemost | year= 1991 | volume= 17 Suppl 3 | issue= | pages= 304-12 | pmid=1754886 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1754886 }} </ref> | ||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | {| style="cellpadding=0; cellspacing= 0; width: 600px;" | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align=center |'''5 points''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align=center | '''3 points''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align=center | '''2 points''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align=center | '''1 point''' | | style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align="center" |'''5 points''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align="center" | '''3 points''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align="center" | '''2 points''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 25%" align="center" | '''1 point''' | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | ❑ [[Stroke]] (in the previous month) <br> ❑ Fracture of the hip, pelvis, or leg <br> ❑ Elective [[arthroplasty]] <br> ❑ Acute [[spinal cord injury]] (in the previous month) | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | ❑ [[Stroke]] (in the previous month) <br> ❑ Fracture of the hip, pelvis, or leg <br> ❑ Elective [[arthroplasty]] <br> ❑ Acute [[spinal cord injury]] (in the previous month) | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | ❑ [[Age]]≥ 75 years <br> ❑ Prior episodes of [[VTE]] <br>❑ Positive family history for [[VTE]] <br> ❑ [[Prothrombin 20210 A]] <br> ❑ [[Factor V Leiden]] <br> ❑ [[Lupus anticoagulant]]s <br> ❑ [[Anticardiolipin antibodies]] <br> ❑ High [[homocysteine]] in the blood <br> ❑ [[Heparin induced thrombocytopenia]] <br> ❑ Other congenital or acquired [[thrombophilia]] | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | ❑ [[Age]]≥ 75 years <br> ❑ Prior episodes of [[VTE]] <br>❑ Positive family history for [[VTE]] <br> ❑ [[Prothrombin 20210 A]] <br> ❑ [[Factor V Leiden]] <br> ❑ [[Lupus anticoagulant]]s <br> ❑ [[Anticardiolipin antibodies]] <br> ❑ High [[homocysteine]] in the blood <br> ❑ [[Heparin induced thrombocytopenia]] <br> ❑ Other congenital or acquired [[thrombophilia]] | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left | ❑ Age: 61-74 years <br> ❑ [[Arthroscopy|Arthroscopic surgery]] <br> ❑ [[Laparoscopy]] lasting more than 45 minutes <br> ❑ [[General surgery]] lasting more than 45 minutes <br> ❑ [[Cancer]] <br> ❑ [[Plaster cast]] <br> ❑ Bed bound for more than 72 hours <br> ❑ Central venous access | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | ❑ Age: 61-74 years <br> ❑ [[Arthroscopy|Arthroscopic surgery]] <br> ❑ [[Laparoscopy]] lasting more than 45 minutes <br> ❑ [[General surgery]] lasting more than 45 minutes <br> ❑ [[Cancer]] <br> ❑ [[Plaster cast]] <br> ❑ Bed bound for more than 72 hours <br> ❑ Central venous access | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left| ❑ Age 41-60 years <br> ❑ [[BMI]] > 25 Kg/m<sup>2</sup> <br> ❑ Minor surgery <br> ❑ [[Edema]] in the lower extremities <br> ❑ [[Varicose veins]] <br> ❑ [[Pregnancy]] <br> ❑ [[Post-partum]] <br> ❑ [[Oral contraceptive]] <br> ❑ [[Hormonal therapy]] <br> ❑ Unexplained or recurrent [[abortion]] <br> ❑ [[Sepsis]] (in the previous month) <br> ❑ Serious lung disease such as pneumonia (in the previous month) <br> ❑ Abnormal [[pulmonary function test]] <br> ❑ [[Acute myocardial infarction]] <br> ❑ [[Congestive heart failure]] (in the previous month) <br> ❑ Bed rest <br> ❑ [[Inflammatory bowel disease]] | | style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | ❑ Age 41-60 years <br> ❑ [[BMI]] > 25 Kg/m<sup>2</sup> <br> ❑ Minor surgery <br> ❑ [[Edema]] in the lower extremities <br> ❑ [[Varicose veins]] <br> ❑ [[Pregnancy]] <br> ❑ [[Post-partum]] <br> ❑ [[Oral contraceptive]] <br> ❑ [[Hormonal therapy]] <br> ❑ Unexplained or recurrent [[abortion]] <br> ❑ [[Sepsis]] (in the previous month) <br> ❑ Serious lung disease such as pneumonia (in the previous month) <br> ❑ Abnormal [[pulmonary function test]] <br> ❑ [[Acute myocardial infarction]] <br> ❑ [[Congestive heart failure]] (in the previous month) <br> ❑ Bed rest <br> ❑ [[Inflammatory bowel disease]] | ||
|} | |} | ||
Latest revision as of 21:17, 6 March 2018
Resident Survival Guide |
Deep Vein Thrombosis Microchapters |
Diagnosis |
---|
Treatment |
Special Scenario |
Trials |
Case Studies |
Deep vein thrombosis assessment of probability of subsequent VTE and risk scores On the Web |
FDA on Deep vein thrombosis assessment of probability of subsequent VTE and risk scores |
CDC on Deep vein thrombosis assessment of probability of subsequent VTE and risk scores |
Deep vein thrombosis assessment of probability of subsequent VTE and risk scores in the news |
Blogs on Deep vein thrombosis assessment of probability of subsequent VTE and risk scores |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Synonyms and keywords: DVT prophylaxis, VTE prophylaxis
Overview
Venous thromboembolism (VTE) is a disease associated with morbidity and mortality; therefore, VTE prophylaxis is indicated among specific categories of patients at elevated risk for VTE. Several scores have been developed for the assessment of risk of subsequent VTE such as the Padua prediction score and the IMPROVE score among hospitalized medically ill patients, and Roger's score and Caprini score among surgical patients.
Assessment of the Risk of Subsequent VTE in Medically Ill Patients
Padua Prediction Score for VTE
Calculation of the Padua Prediction Score
Shown below is a table depicting Padua predictive score for VTE among hospitalized medical patients.
Variable | Score |
Active cancer | 3 |
Previous VTE | 3 |
Decreased mobility | 3 |
Thrombophilia | 3 |
Previous trauma or surgery within that last month | 2 |
Age≥ 70 | 1 |
Heart and/or respiratory failure | 1 |
Ischemic stroke or acute myocardial infarction | 1 |
Acute rheumatologic disorder and/or acute infection | 1 |
Obesity | 1 |
Hormonal therapy | 1 |
Interpretation of the Padua Prediction Score
The interpretation of the score is as follows:
- Score≥ 4: High risk for VTE
- Score< 4: Low risk for VTE[1]
IMPROVE Predictive Score for VTE
Calculation of the IMPROVE Predictive Score
Variable | Score[2] |
Prior episode of VTE | 3 |
Thrombophilia | 3 |
Malignancy | 1 |
Age more than 60 years | 1 |
Interpretation of the IMPROVE Predictive Score
Score | Predicted VTE risk through 3 months[2] |
0 | 0.5% |
1 | 1.0% |
2 | 1.7% |
3 | 3.1% |
4 | 5.4% |
5-8 | 11% |
IMPROVE Associative Score for VTE
IMPROVE associative risk score assesses the risk of VTE among hospitalized medical patients. While the IMPROVE predictive score includes 4 independent risk factors for VTE which are present at admission, IMPROVE associative score includes 7 variables present either at admission or during hospitalization; however the timing of the presence of some of the factors compared to the onset of VTE is not available.[2]
Calculation of the IMPROVE Associative Score
Variable | Score[2] |
Prior episode of VTE | 3 |
Thrombophilia | 2 |
Paralysis of the lower extremity during the hospitalization | 2 |
Current malignancy | 2 |
Immobilization for at least 7 days | 1 |
ICU or CCU admission | 1 |
Age more than 60 years | 1 |
Interpretation of the IMPROVE Associative Score
Score | Predicted VTE risk through 3 months[2] |
0 | 0.4% |
1 | 0.6% |
2 | 1.0% |
3 | 1.7% |
4 | 2.9% |
5-10 | 7.2% |
Assessment of the Risk of Subsequent VTE in Surgery Patients
Roger's Score
Calculation of Roger's Score
Variable | Score[3] |
Pulmonary and hemic surgery | 9 |
Thoracoabdominal aneurysm, embolectomy/thrombectomy, venous reconstruction, and endovascular repair surgery | 7 |
Aneurysm surgery | 4 |
Mouth or palate surgery | 4 |
Stomach or intestines surgery | 4 |
Integument surgery | 3 |
Hernia surgery | 2 |
American Society of Anesthesiologists (ASA) physical status classification 3, 4, or 5 | 2 |
ASA physical status classification 2 | 1 |
Female | 1 |
Work relative value unit > 17 | 3 |
Work relative value unit 10−17 | 2 |
Disseminated malignancy | 2 |
Chemotherapy for cancer in the last 30 days | 2 |
Serum sodium > 145 mmol/L pre-op | 2 |
Transfusion > 4 U packed red blood cells within 72 h pre-op | 2 |
Dependency on ventilator | 2 |
Wound class (clean/contaminated) | 1 |
Hematocrit ≤ 38% pre-op | 1 |
Bilirubin > 1.0 mg/dL pre-op | 1 |
Dyspnea | 1 |
Albumin ≤ 3.5 mg/dL | 1 |
Emergency operation | 1 |
ASA physical status classification 1 | 0 |
Work relative value unit < 10 | 0 |
Male | 0 |
Interpretation of Roger's Score
The Rogers score is calculated by adding the scores of all factors present in the patient. The Rogers score is interpreted in the following way:[3]
- Score 1-6: Low
- Score 7-10: Moderate
- Score > 10: High
Caprini Risk Assessment Model
Calculation of the Caprini Risk Score
Shown below is a table depicting the different scores for the factors included in the Caprini score.[4]
5 points | 3 points | 2 points | 1 point |
❑ Stroke (in the previous month) ❑ Fracture of the hip, pelvis, or leg ❑ Elective arthroplasty ❑ Acute spinal cord injury (in the previous month) |
❑ Age≥ 75 years ❑ Prior episodes of VTE ❑ Positive family history for VTE ❑ Prothrombin 20210 A ❑ Factor V Leiden ❑ Lupus anticoagulants ❑ Anticardiolipin antibodies ❑ High homocysteine in the blood ❑ Heparin induced thrombocytopenia ❑ Other congenital or acquired thrombophilia |
❑ Age: 61-74 years ❑ Arthroscopic surgery ❑ Laparoscopy lasting more than 45 minutes ❑ General surgery lasting more than 45 minutes ❑ Cancer ❑ Plaster cast ❑ Bed bound for more than 72 hours ❑ Central venous access |
❑ Age 41-60 years ❑ BMI > 25 Kg/m2 ❑ Minor surgery ❑ Edema in the lower extremities ❑ Varicose veins ❑ Pregnancy ❑ Post-partum ❑ Oral contraceptive ❑ Hormonal therapy ❑ Unexplained or recurrent abortion ❑ Sepsis (in the previous month) ❑ Serious lung disease such as pneumonia (in the previous month) ❑ Abnormal pulmonary function test ❑ Acute myocardial infarction ❑ Congestive heart failure (in the previous month) ❑ Bed rest ❑ Inflammatory bowel disease |
Interpretation of the Caprini Risk Score
The Caprini score is calculated by adding the scores of all factors present in the patient. The Caprini score is interpreted in the following way:[4][5]
- Score 0-1: Low risk of VTE
- Score 2: Moderate of VTE
- Score 3-4: High risk of VTE
- Score ≥ 5: Highest risk for VTE
References
- ↑ Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M; et al. (2010). "A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score". J Thromb Haemost. 8 (11): 2450–7. doi:10.1111/j.1538-7836.2010.04044.x. PMID 20738765.
- ↑ 2.0 2.1 2.2 2.3 2.4 Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH; et al. (2011). "Predictive and associative models to identify hospitalized medical patients at risk for VTE". Chest. 140 (3): 706–14. doi:10.1378/chest.10-1944. PMID 21436241.
- ↑ 3.0 3.1 Rogers SO, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF (2007). "Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study". J Am Coll Surg. 204 (6): 1211–21. doi:10.1016/j.jamcollsurg.2007.02.072. PMID 17544079.
- ↑ 4.0 4.1 Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F (1991). "Clinical assessment of venous thromboembolic risk in surgical patients". Semin Thromb Hemost. 17 Suppl 3: 304–12. PMID 1754886.
- ↑ Caprini JA (2005). "Thrombosis risk assessment as a guide to quality patient care". Dis Mon. 51 (2–3): 70–8. doi:10.1016/j.disamonth.2005.02.003. PMID 15900257.